Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Manna SX (specifically the Vella product) is a topical serum containing hemp-derived cannabidiol (CBD) formulated with proprietary liposomal technology for female sexual enhancement. Developed by Manna Molecular Science, the product is designed to promote smooth muscle relaxation and engorgement in women's genital tissue, facilitating a physiological response similar to a 'female erection.' The development was led by Dr. Harin Padma-Nathan, a former clinical investigator for Viagra, using an evidence-based approach including organ bath studies and at-home case studies to demonstrate efficacy in improving sexual health and pleasure. The serum is condom-compatible, paraben-free, and available in both multi-use and single-use formats.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Manna SX.